# Benjamin Kasenda

Source: https://onco.cc/people/benjamin-kasenda/  
OnCo record `benjamin-kasenda` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.

## Summary

Benjamin Kasenda is a senior physician in internal medicine and haematology/oncology at Universitätsspital Basel, working within the Tumour Centre with a focus on gastrointestinal tumours and lymphoma. He has co-authored prospective phase 2 trials in the Lancet Haematology evaluating high-dose chemotherapy with autologous stem-cell transplantation for primary CNS lymphoma, including in older patients.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: clinician-scientist; lymphoma; haematology
- Role: Senior Physician, Medical Oncology and Haematology (Tumour Centre)
- Specialisms: Primary CNS lymphoma; Gastrointestinal tumours; Haematology-oncology; Clinical trials

## Sources

- Institution profile: https://www.unispital-basel.ch/en/tumorzentrum
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Kasenda+B%5BAuthor%5D

## Connected records

- cancers: [Primary CNS lymphoma](https://onco.cc/cancers/primary-cns-lymphoma/)
- institutions: [University Hospital Basel / Tumour Centre](https://onco.cc/institutions/usb-basel/)

---
JSON: https://onco.cc/api/v1/entities/benjamin-kasenda.json